ZURICH (Reuters) - Drugmaker Roche on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug Administration for a test to quickly detect whether a patient has SARS-CoV-2 or one of two forms of influenza
SUBSCRIBE
Biohealth Innovation
Founding Member of
